共 50 条
- [36] Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (01): : 24 - 30
- [38] A Case of t(3;3)(q21;q26.2) Associated with Severe Multi lineage Dysplasia and Multi-drug Resistance in Blastic Crisis of Chronic Myelogenous Leukemia KOREAN JOURNAL OF LABORATORY MEDICINE, 2010, 30 (06): : 595 - 599